HARMONYBIOS LIMITED – Trademark Portfolio

Entity Type: 16

HARMONYBIOS LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include KTM. The owner is based in Auckland.

19 Williams Road, Hobsonville,

Auckland 0618 , NZ

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KTM
KTM
Pending 2026
KTM
KTM
Registered 2025

Trademark Classifications

HARMONYBIOS LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does HARMONYBIOS LIMITED have?

HARMONYBIOS LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does HARMONYBIOS LIMITED file in?

HARMONYBIOS LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HARMONYBIOS LIMITED's most well-known trademarks?

HARMONYBIOS LIMITED's registered trademark portfolio includes well-known marks such as KTM. These are among 1 currently registered trademark in the portfolio.

What is HARMONYBIOS LIMITED's trademark registration success rate?

HARMONYBIOS LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.